Plunge in clinical drug trials makes Britain an urgent case for treatment theguardian.com/business/2023/…

Congratulations to the haematology team at The Royal Marsden NHS Foundation Trust who were presented with the Myeloma UK Clinical Service Excellence Programme (CSEP) Award for the second time yesterday. Recognising their commitment to raising the bar for treatment and providing compassionate care 🧡

Join the WM community to learn, connect and collaborate at the first European WM Patient Summit. We'll be in Birmingham, live streaming with our IWMF friends in Amsterdam to give you even more expert advice. Tickets are limited, so grab yours today: ow.ly/laba50PmtTb

Emma Thistlethwayte, Teenage & Young Adult (TYA) Lead Nurse at The Royal Marsden, discusses how research in to breaking the stigma around mental health for TYA cancer patients led to the development of a tailored app: bit.ly/3qCG1xW

Calling all BSH Members: Are you a consultant haematologists involved in the field of haemato-oncology, with a particular interest in myeloproliferative neoplasms? The Haematology Oncology task force is looking for one new member. b-s-h.org.uk/about-us/get-i…

We recently caught up with the team at one of our newest TAP Centres at The Royal Marsden NHS Foundation Trust to understand why they applied to become a part of the TAP Network and how their work will benefit #bloodcancer patients across the Surrey area..... #Leukaemia #ClinicalTrials

Make yourself a cup of tea, put your feet up and join us online for our European Patient Forum. We've a packed programme, from symptom management to active monitoring. Register to join us online at wmuk.org.uk/european-wm-fo… #EuropeanWMPatientForum #WMAwareness #WMUK

Big UK #CLL news More excellent options for our patients! #zanubrutinib #lymsm

The Big Give is coming soon! It’s a great opportunity for us to double donations to WMUK. We thought you’d like to know a bit more about it, so here’s a lovely film to explain what it’s all about! youtube.com/watch?v=4ujJN5… More details to come. #BigGive #WMUK

New paper⏩ -Sadly a negative international trial despite real initial hope -So much more to do for pts with this awful dx #TPLL #lymsm Limited efficacy for ibrutinib & venetoclax in T-prolymphocytic leukemia:results from phase 2 international study ashpublications.org/bloodadvances/…

For those interested: consider applying for a new permanent myeloma consultant post The Royal Marsden NHS Foundation Trust . Join a great team and an expanding myeloma service covering all aspects of myeloma care and clinical research, including T-cell based therapies! beta.jobs.nhs.uk/candidate/joba…

A jam-packed programme filled with clinicians, nurses, patients and experts from around Europe. WMUK and IWMF have been working hard to create a programme that meets the needs of patients and families, as told to us by patients and families. The agenda: bit.ly/3xxegKD

British Journal of Haematology | Wiley Online Library onlinelibrary.wiley.com/doi/10.1111/bj… I’m delighted to present and share the first ever study looking at checkpoint inhibition in WM. Thanks to all our collaborators especially Toby Eyre , Shirley D’Sa and all the trial patients

With exclusive sessions, the chance to ask world-leading experts questions, and the opportunity to have the first look at our new myWM app, the European WM Pateitn Forum is unmissable for anyone affected by WM. Book your tickets to reserve your spot today: bit.ly/3VJHPAD

It's not too late to book your tickets to the European WM Patient Forum. This event is a one of its kind, bringing together top experts so that you can get the latest updates and information, and even the chance to ask questions directly. Book here: bit.ly/3VJHPAD

💙 Living with WM? Let’s Connect! Join our Networking Session on 21 May in Chantilly, France, designed for those living with WM. A stronger community starts with YOU. Register today: iwmf.com/iwmf-european-… #IWMF #2025EEF #Waldenstrom’s

Great success of the UK Chronic Lymphocytic Leukaemia (CLL) Forum session at #BSH2025. Many thanks to Prof Paul Moss, Prof Martin Dyer and Dima El-Sharkawi for their valuable, insightful and engaging talks. See you in October in our Clinical Sciences meeting.

In an interview from #EHA2025, the lovely Dima (The Royal Marsden NHS Foundation Trust) shares the results of the Waldenström’s macroglobulinemia cohort from a Phase I clinical trial investigating bexobrutideg, a BTK degrader, in B-cell malignancies: 👉 ow.ly/2GpH50WfXfS 👈 #LYMsm #CTSM